Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stock Upgrades: TASER Set for Stunning Success?

By

Wall Street ratings agencies set the tone for today's stock market.

PrintPRINT
MINYANVILLE ORIGINAL Netflix (NFLX) fell 5.78% after ominous news about the company was reported by Variety, home to the all-time iconic headline of the Crash of '29. Vivus (VVUS) climbed 3.85% after an unexpectedly early introduction of its obesity drug, and a fat finger was figured for a sudden fall off in oil.

Chicago's classrooms still stand idle, but Virco Manufacturing (VIRC), maker of school furniture, is having considerably more success with empty chairs than Clint Eastwood. Its shares, up 3.24% in regular trading, rose another 8.73% after-hours.

No top-tier economic data due today, but quarterly earnings announcements are expected from FedEx (FDX), Manchester United (MANU), Misonix (MSON), Schiff Nutrition International (SHF), and Versar (VSR).

Broadcom (BRCM): Shares are up before the bell on an upgrade to Outperform from Sector Perform at RBC Capital, whose target is also taken up by $8 to $46. Catalysts include leverage to rising unit growth.

General Motors (GM): GM gets upgraded to Buy from Neutral at Buckingham.

Jive Software (JIVE): JIVE gets upgraded to Outperform from Market Perform with Wells Fargo.

Lamar Advertising (LAMR): LAMR is upgraded to Conviction Buy from Neutral at Goldman Sachs, which also takes its target up to $42 from $34.

L'Oreal (LRLCY): Société Générale gives the cosmetics company a Buy-from-Hold boost.

Manhattan Associates (MANH): MANH is moved to Buy from Hold at ThinkEquity amid improving IT spending trends.

OCZ Technology (OCZ): Shares are upgraded to Buy from Hold at Craig Hallum.

Pall Corp. (PLL): Bank of America-Merrill Lynch lifts the stock to Neutral from Underperform.

Rubicon Technology (RBCN): The company is raised to Buy from Hold at ThinkEquity.

TASER International (TASR): JPMorgan moves the stun gun maker to Overweight from Neutral amid a belief its growth will be driven by the X2/Axon product cycle. The target price is also taken up, to $7.50 from $6.

(See also: Stock Downgrades: Panera Bread Fresh Out of Dough and New Stock Coverage: A.O. Smith Can Keep Up With the Dow Joneses.)
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE